MedTrace Logo

Radiologic Evaluation and Breast Density (READ)

NCT00117663 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1704

Last updated 2024-04-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether cessation of hormone replacement therapy for one or two months before a screening mammogram will improve its performance by decreasing breast density.

Conditions

Interventions

OTHER

temporary discontinuation of hormone therapy for 1 month

temporary discontinuation of hormone replacement therapy for 1 month prior to screening mammogram.

OTHER

temporary discontinuation of hormone therapy for 2 months

temporary discontinuation of hormone replacement therapy for 2 months prior to screening mammogram

Sponsors & Collaborators

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Diana SM Buist, Ph.D. · Kaiser Permanente

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-11-30
Primary Completion
2007-11-30
Completion
2007-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00117663 on ClinicalTrials.gov